Radiogenic Disease Dose-Based Pathway

38 CFR §3.311 provides a separate pathway for veterans who were exposed to ionizing radiation in service but whose activity is not on the §3.309(d) list, or whose radiogenic disease is not among the §3.309(d)(2) presumptive conditions. It relies on dose assessment rather than an automatic presumption. This page reproduces the regulation with plain-English context.

How §3.311 works

Section 3.311 is not an automatic presumption like §3.309(d). It is a procedural pathway: when a radiogenic disease first becomes manifest after service and was not manifest to a compensable degree within the presumptive periods of §3.307 or §3.309, and it is contended the disease resulted from in-service radiation exposure, the VA performs a dose assessment and refers the claim to the Under Secretary for Benefits for further consideration.

Regulation text (verbatim, §3.311(a)(1)): In all claims in which it is established that a radiogenic disease first became manifest after service and was not manifest to a compensable degree within any applicable presumptive period as specified in § 3.307 or § 3.309, and it is contended the disease is a result of exposure to ionizing radiation in service, an assessment will be made as to the size and nature of the radiation dose or doses.

Three threshold requirements. Under §3.311(b)(1), a claim is referred for further consideration only if all three are met:

  1. The veteran was exposed to ionizing radiation (atmospheric testing, Hiroshima/Nagasaki occupation Sept 1945 – Jul 1946, or other activities as claimed);
  2. The veteran subsequently developed a radiogenic disease (listed below, or otherwise supported by competent scientific or medical evidence);
  3. The disease first became manifest within the manifestation period specified for that disease.

Radiogenic diseases (§3.311(b)(2))

"Radiogenic disease" means a disease that may be induced by ionizing radiation. The regulation lists the following:

  • All forms of leukemia except chronic lymphatic (lymphocytic) leukemia
  • Thyroid cancer
  • Breast cancer
  • Lung cancer
  • Bone cancer
  • Liver cancer
  • Skin cancer
  • Esophageal cancer
  • Stomach cancer
  • Colon cancer
  • Pancreatic cancer
  • Kidney cancer
  • Urinary bladder cancer
  • Salivary gland cancer
  • Multiple myeloma
  • Posterior subcapsular cataracts
  • Non-malignant thyroid nodular disease
  • Ovarian cancer
  • Parathyroid adenoma
  • Tumors of the brain and central nervous system
  • Cancer of the rectum
  • Lymphomas other than Hodgkin's disease
  • Prostate cancer
  • Any other cancer
Other diseases and polycythemia vera. If a claim is based on a disease other than those listed, the VA will nevertheless consider the claim under §3.311 provided the claimant has cited or submitted competent scientific or medical evidence that the claimed condition is a radiogenic disease. Polycythemia vera is not on the listed radiogenic diseases, but the regulation permits consideration under this "other disease" provision.

Manifestation periods (§3.311(b)(5))

The disease must first become manifest within the period specified below. If it manifests outside that window, §3.311 does not apply.

DiseaseManifestation period
Bone cancerMust become manifest within 30 years after exposure.
LeukemiaMay become manifest at any time after exposure.
Posterior subcapsular cataractsMust become manifest 6 months or more after exposure.
Other listed diseasesMust become manifest 5 years or more after exposure.

Dose assessment process

Once a claim meets the three threshold requirements, the VA develops a dose estimate:

  • Atmospheric nuclear test participation claims. Dose data is requested from the Department of Defense in all cases.
  • Hiroshima/Nagasaki occupation claims (prior to July 1, 1946). Dose data is requested from the Department of Defense in all cases.
  • Other exposure claims. Records concerning the veteran's exposure are requested, including the DD Form 1141 (Record of Occupational Exposure to Ionizing Radiation), if maintained, and service medical records. Records are forwarded to the Under Secretary for Health, who prepares a dose estimate based on available methodologies.
Exposure concession rule (§3.311(a)(4)): For atmospheric nuclear test participation claims and Hiroshima/Nagasaki occupation claims, if military records do not establish presence at or absence from a site at which exposure to radiation is claimed to have occurred, the veteran's presence at the site will be conceded. Neither the veteran nor the veteran's survivors may be required to produce evidence substantiating exposure if the information in the veteran's service records or other records maintained by the Department of Defense is consistent with the claim.

Independent expert referral. When a material difference exists between a credible-source estimate submitted by or on behalf of the claimant and official military dose data, ordinarily, one estimate at least double the other, the estimates are referred to an independent expert selected by the Director of the National Institutes of Health. "Highest-in-range" rule applies: when dose estimates are reported as a range, exposure at the highest level of the reported dose range is presumed.

Factors for consideration (§3.311(e))

In deciding whether a veteran's disease resulted from in-service radiation exposure, the regulation directs consideration of:

  1. The probable dose, in terms of dose type, rate, and duration as a factor in inducing the disease, taking into account any known limitations in the dosimetry devices employed.
  2. The relative sensitivity of the involved tissue to induction, by ionizing radiation, of the specific pathology.
  3. The veteran's gender and pertinent family history.
  4. The veteran's age at time of exposure.
  5. The time-lapse between exposure and onset of the disease.
  6. The extent to which exposure to radiation, or other carcinogens, outside of service may have contributed to development of the disease.

Willful misconduct / supervening cause. Service connection will not be established under §3.311 if the disease is due to the veteran's own willful misconduct, or if there is affirmative evidence that a supervening, nonservice-related condition or event is more likely the cause.

Other pathways if §3.311 does not apply

  • §3.309(d) automatic presumption. If the veteran participated in one of the eight listed "radiation-risk activities" and has one of the 21 listed diseases, that presumption applies instead of the dose-based process here. See the §3.309(d) reference page →
  • Direct service connection. A veteran may always attempt direct service connection by showing a current diagnosis, an in-service event or exposure, and a medical nexus linking the two. See the three elements of service connection →

Source and currency

Authority: 38 U.S.C. 501; Pub. L. 98-542. Originally codified at 50 FR 34459 (Aug. 26, 1985), as amended through 67 FR 6871 (Feb. 14, 2002).

Regulation text: 38 CFR §3.311 on eCFR.gov (official text, always current).

Data on this page: Reproduced from the eCFR Title 38 snapshot dated 2026-04-20. The eCFR link above is authoritative if it differs.

Scope and limitations

Not the exclusive pathway. This page describes one specific pathway (§3.311). Other regulations, direct service connection, and the §3.309(d) automatic presumption may apply separately.

Not legal advice, not a claim filing. This page provides factual reference only. It is not legal advice, does not establish representation, and does not constitute the filing of any claim. For case-specific guidance, find an accredited VSO representative.

Data vintage. Regulatory text pulled from eCFR on 2026-04-22. Regulations are amended periodically; always verify against the eCFR link above.

Dose-based, not automatic. §3.311 is a procedural pathway requiring case-by-case adjudication. Eligibility under §3.311 is not a guarantee of service connection.

Related reference pages